We, therefore, aimed to evaluate whether histology-specific expression of FOLH1 may show patterns suggestive of tumor specificity for tumor types known to respond well to PSMA radioligand interventions or show significant uptake on diagnostic PSMA PET imaging. This evidence concerns the gene FOLH1 and neoplasm.